KLK3 and Familial prostate cancer: The analysis based on MIC-1 and PSA concentrations in serum with the patient with prostate cancer status improved the specificity of the diagnosis without compromising the high sensitivity of the PSA test alone and has potential for the prognosis for patient therapy strategies [71].